Moss Adams Wealth Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History
Moss Adams Wealth Advisors LLC
- $946 Billion
- Q4 2024
A detailed history of Moss Adams Wealth Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Moss Adams Wealth Advisors LLC holds 1,357 shares of REGN stock, worth $926,939. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,357
Previous 434
212.67%
Holding current value
$926,939
Previous $456 Million
111.87%
% of portfolio
0.1%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,496Shares Held
82.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.37 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.77 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.12 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.35 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.94 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...